Dalvance is a second-generation, semi-synthetic lipoglycopeptide. The Food and Drug Administration (FDA) has expanded the approval of Dalvance ® (dalbavancin) to include treatment of acute bacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results